About: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.84 (+2.11%)
PBMNASDAQPsyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd. Common Shares share price
PBM price activity
Último preço
$ 4,840
Variação (24h)
0,10 USD (2,11%)
Volume
84.51K
Volume (média 4 sem.)
-
Abertura
$ 4,68
Variação do dia
$ 4,55 - $ 4,98
Fechamento anterior
$ 4,74
Último negócio
09 Sep, 8:28 pm GMT+0
Atrasado
09 Sep, 8:28 pm GMT+0
PBM price performance
Atrasado
09 Sep, 8:28 pm GMT+0
quote.marketSignals